625 9th Street North
Suite 201
Naples, FL 34102
ph: 239.261.2000
fax: 239.261.2266
info
Southwest Florida Research (SWFR) is a research center of excellence for the administration of Phase II-IV clinical trials in pharmaceutical and medical devices.
Our site research organization is committed to exceeding the needs and expectations of our clients by providing innovative, professional and superior quality service with integrity and reliability.
Southwest Florida Research (SWFR) is a research center of excellence for the administration of Phase II-IV clinical trials in pharmaceutical and medical devices.
Our site research organization is committed to exceeding the needs and expectations of our clients by providing innovative, professional and superior quality service with integrity and reliability.
WHAT WE DO
Founded in 2010, Southwest Florida Research (SWFR) grew out of the clinical research division of the Southwest Institute for Cardiovascular Fitness and Treatment (SWICFT). The company is designed as a clinical research collaborative dedicated to partnering pharmaceutical companies with area physicians to find new cures to help patients better manage their healthcare. We share in the commitment and dedication to providing cutting edge therapy that can assist in managing patients' chronic medical conditions today and for a lifetime.
In the clinical trials area, SWFR offers investigational therapies for indications such as Congestive Heart Failure, Diabetes, and much more. We offer new and existing therapies that manage conditions where other medical therapies may have failed. Each and every patient at SWFR receives the highest quality medical care. We notify the patient's primary care physician of enrollment and ongoing status and provide a full report at the conclusion of each study.
We are proud to have a number of sub-specialists, internists and others available to work with us on clinical trials in many other clinical areas including cardiology, gastroenterology, neurology, internal medicine, and many others.
OUR MISSION
CURRENT TRIALS
ENGAGE AF (TIMI-49)
A Study for the Evaluation of Efficacy and Safety of DU-176b Vs. Warfarin (Coumadin) in Subjects with Atrial Fibrillation (Daiichi Sankyo)
ACTIVE–CLOSED TO ENROLLMENT
PI: SWICFT/ Cardiology, Internal Medicine
SAVOR (TIMI 53)
A Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes (AstraZeneca AB)
ACTIVE-CLOSED TO ENROLLMENT
PI: SWICFT/ Cardiology, Endocrinology, Internal Medicine
PEGASUS (TIMI-54)
A Trial to Assess the Prevention of Thrombotic Events with Ticagrelor compared to a Placebo on Patients on ASA (Aspirin) Therapy and a Recent History of Myocardial Infarction (AstraZeneca AB)
ACTIVE-ENROLLING PATIENTS
PI: SWICFT/ Cardiology, Internal Medicine
ALECARDIO
A Cardiovascular Outcomes Study to Evaluate the Potential of Aleglitazar to reduce Cardiovascular Risk in Patients with a Recent Acute Coronary Syndrome Event and Type 2 Diabetes Mellitus (Roche)
ACTIVE-ENROLLING PATIENTS
PI: SWICFT/ Cardiology, Endocrinology, Internal Medicine
SAPPHIRE
Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy (Cordis)
ACTIVE-ENROLLING PATIENTS
PI: Vascular Group of Naples/ Vascular Surgery
REVEAL (TIMI-55)
A Large-scale, Randomized Placebo-controlled Trial of the Clinical Effects of Anacetrapib Among People With Established Vascular Disease (Merck)
SITE ACCEPTED-IN CONTRACTING
PI: SWICFT/ Cardiology, Internal Medicine

If you would be interested in learning more about any of our current studies, or to find out if you are a potential candidate, please either fill out the form below or call (239) 261-2000 and ask for Lori Leo. RN. Thank you for considering participation in this important research, and we hope to hear from you soon.
Copyright 2009 SWICFT Institute of Southwest Florida. All rights reserved.
625 9th Street North
Suite 201
Naples, FL 34102
ph: 239.261.2000
fax: 239.261.2266
info